Filtrera efter Last updated date SelectEfterFöreFrom - To Date Slutdatum Denna vecka Den här månaden Förra veckan Förra månaden Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Lämna detta fält tomt Filter Resultat (3827) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Lämna detta fält tomt EMA Management Board: highlights of October 2023 meeting 6 oktober 2023NewsCorporate Revised transparency rules for the EU Clinical Trials Information System (CTIS) 6 oktober 2023News EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna 5 oktober 2023NewsHumanMedicines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 September 2023 29 september 2023NewsHumanPharmacovigilanceReferrals EMA recommends non-renewal of authorisation of multiple myeloma medicine Blenrep 28 september 2023NewsHumanMedicines Towards a permanent collaboration framework for EMA and Health Technology Assessment bodies 15 september 2023NewsHuman Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 September 2023 15 september 2023NewsHumanCOVID-19MedicinesReferrals Spikevax: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5 14 september 2023NewsHumanCOVID-19Medicines PRAC recommends new measures to avoid topiramate exposure in pregnancy 1 september 2023NewsHumanReferrals Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 August 2023 1 september 2023NewsHumanPharmacovigilanceReferrals 1 … 26 27 28 29 30 Page 30 of 383 31 32 33 34 … 383
EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna 5 oktober 2023NewsHumanMedicines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 September 2023 29 september 2023NewsHumanPharmacovigilanceReferrals
EMA recommends non-renewal of authorisation of multiple myeloma medicine Blenrep 28 september 2023NewsHumanMedicines
Towards a permanent collaboration framework for EMA and Health Technology Assessment bodies 15 september 2023NewsHuman
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 September 2023 15 september 2023NewsHumanCOVID-19MedicinesReferrals
Spikevax: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5 14 september 2023NewsHumanCOVID-19Medicines
PRAC recommends new measures to avoid topiramate exposure in pregnancy 1 september 2023NewsHumanReferrals
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 August 2023 1 september 2023NewsHumanPharmacovigilanceReferrals